A share price of RAPT Therapeutics Inc [RAPT] is currently trading at $30.14, up 3.57%. An important factor to consider is whether the stock is rising or falling in short-term value. The RAPT shares have gain 14.25% over the last week, with a monthly amount glided 136.76%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
RAPT Therapeutics Inc [NASDAQ: RAPT] stock has seen the most recent analyst activity on September 26, 2025, when Leerink Partners upgraded its rating to a Outperform but kept the price target unchanged to $37 for it. Previously, JP Morgan upgraded its rating to Neutral on July 30, 2025, and kept the price target unchanged to $14. H.C. Wainwright upgraded its rating to a Buy but stick to its price target of $10 on December 26, 2024. Stifel downgraded its rating to a Hold and reduced its price target to $2 on November 13, 2024. Piper Sandler downgraded its rating to Neutral for this stock on November 11, 2024, and downed its price target to $2. In a note dated November 11, 2024, JP Morgan downgraded an Underweight rating on this stock.
RAPT Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $5.67 and $29.73. Currently, Wall Street analysts expect the stock to reach $23 within the next 12 months. RAPT Therapeutics Inc [NASDAQ: RAPT] shares were valued at $30.14 at the most recent close of the market. An investor can expect a potential drop of -23.69% based on the average RAPT price forecast.
Analyzing the RAPT fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.6, Equity is -0.68 and Total Capital is -0.68. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 28.22 points at the first support level, and at 26.30 for the second support level. However, for the 1st resistance point, the stock is sitting at 31.91, and for the 2nd resistance point, it is at 33.68.
Ratios To Look Out For
To put it in perspective, the Current Ratio for RAPT Therapeutics Inc [NASDAQ:RAPT] is 13.25. On the other hand, the Quick Ratio is 13.25, and the Cash Ratio is 3.21.
